US 11027008
Recombinant mumps virus vaccine
granted A61KA61K2039/5254A61K2039/5256
Quick answer
US patent 11027008 (Recombinant mumps virus vaccine) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/5254, A61K2039/5256, A61K2039/543, A61K39/12